The under-regulated world of patient services

It’s axiomatic that the trend toward specialty pharmaceuticals is expanding the range of patient-oriented services that the pharma industry is involved in: the very definition of a specialty pharmaceutical includes ones that require patient support. This has also been one […]

Read More

FDA schedules public meetings for DSCSA

FDA is following through on requirements, under the Drug Supply Chain Security Act (DSCSA), to hold public meetings on where it is going with the law, whose implementation started in 2015 and will continue (under current timetables) until 2023. A […]

Read More